AU1673776A - Injectable solution - Google Patents

Injectable solution

Info

Publication number
AU1673776A
AU1673776A AU16737/76A AU1673776A AU1673776A AU 1673776 A AU1673776 A AU 1673776A AU 16737/76 A AU16737/76 A AU 16737/76A AU 1673776 A AU1673776 A AU 1673776A AU 1673776 A AU1673776 A AU 1673776A
Authority
AU
Australia
Prior art keywords
injectable solution
injectable
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU16737/76A
Other languages
English (en)
Inventor
Jean Bru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
U P S A Union De Pharmacologie
Original Assignee
U P S A Union De Pharmacologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U P S A Union De Pharmacologie filed Critical U P S A Union De Pharmacologie
Publication of AU1673776A publication Critical patent/AU1673776A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU16737/76A 1975-08-11 1976-08-11 Injectable solution Expired AU1673776A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524981A FR2320759A1 (fr) 1975-08-11 1975-08-11 Solution d'acide acetylsalicylique extemporanee injectable

Publications (1)

Publication Number Publication Date
AU1673776A true AU1673776A (en) 1978-02-16

Family

ID=9158984

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16737/76A Expired AU1673776A (en) 1975-08-11 1976-08-11 Injectable solution

Country Status (10)

Country Link
JP (1) JPS5241212A (fr)
AU (1) AU1673776A (fr)
BE (1) BE845038A (fr)
DE (1) DE2635843A1 (fr)
ES (1) ES450583A1 (fr)
FR (1) FR2320759A1 (fr)
GB (1) GB1525765A (fr)
NL (1) NL7608951A (fr)
SE (1) SE7608909L (fr)
ZA (1) ZA764781B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021570B2 (ja) * 1978-07-04 1985-05-28 三共株式会社 ド−パ類の高濃度製剤の製法
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
ES2323286T3 (es) * 2005-06-29 2009-07-10 Verisfield (Uk) Ltd. Composiciones farmaceuticas de risperidona en disolucion acuosa.
CN101380329B (zh) * 2008-10-29 2010-11-17 海南本创医药科技有限公司 一种精氨酸阿司匹林及其粉针剂的制备方法
US20120270846A2 (en) * 2009-05-11 2012-10-25 King Saud University Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
CN102531969A (zh) * 2011-12-28 2012-07-04 蚌埠丰原医药科技发展有限公司 一种无菌l-精氨酸的制备方法
BR112018076553A2 (pt) 2016-06-28 2019-04-02 Asamedic As composição de dois componentes.
EP3501523A1 (fr) 2017-12-22 2019-06-26 Asamedic AS Compositions à deux composants contenant de l'acide acétylsalicylique et d'un sel carbonate
EP3501522A1 (fr) 2017-12-22 2019-06-26 Asamedic AS Compositions comprenant de l'acide acétylsalicylique et d'un sel de phosphate
WO2023198294A1 (fr) * 2022-04-14 2023-10-19 Hyloris Developments Sa Composition d'acide acétyl salicylique pour administration intraveineuse, son stockage, sa production et son utilisation

Also Published As

Publication number Publication date
FR2320759A1 (fr) 1977-03-11
BE845038A (fr) 1976-12-01
ZA764781B (en) 1977-07-27
FR2320759B1 (fr) 1979-09-14
SE7608909L (sv) 1977-02-12
ES450583A1 (es) 1978-02-01
DE2635843A1 (de) 1977-02-24
NL7608951A (nl) 1977-02-15
GB1525765A (en) 1978-09-20
JPS5241212A (en) 1977-03-30

Similar Documents

Publication Publication Date Title
JPS5190545A (en) Maikurosutoritsupu * maikuroraininpiidansuhenseiki
GB1542947A (en) Syringe
JPS5196716A (en) ****** *so*******e
JPS5198218A (en) ****** ******e
JPS5237176A (en) Ampule
AU1673776A (en) Injectable solution
GB1557482A (en) Substituted tetranorprostaglandins
JPS5198244A (en) ************** **
JPS51118942A (en) Oscillator
JPS5196648A (en) ******** ***o**
JPS5195575A (en) * ***************
JPS51105406A (en) Senishiito * b * noseizoho
JPS5282059A (en) Wideeband oscillator
JPS5198548A (en) ****** ****
JPS5195062A (en) *********** * ***e**
JPS529638A (en) Tinnelectroplating solution
PH12752A (en) Injectable metromidazole composition
AU1735076A (en) Substituted sulfoximides
JPS5265276A (en) Substituted tetraalkylpiperidinee44oxime
JPS5182028A (en) Tansenioyobi * mataha parupuryushinoseizoho
JPS5197367A (en) **** *******i***************************no
JPS5199905A (en) Chokuheiretsu * heichokuretsuhenkanhoshiki
JPS5180091A (en) Nenchakukenmashi * matahanuno *
JPS5198241A (en) ********so*** *******no
JPS51111319A (en) Oscillator